510(k) · Cleared
ClearedCapiox Cardioplegia
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Terumo Medical Corp. · DTR Heat-Exchanger, Cardiopulmonary Bypass
Cleared on Jun 23, 1999 as substantially equivalent to K934847 (Sorin Biomedical, Inc., 1994) and 1 other predicate after a 343-day review. Its family tree reaches back 1 generation to 1992.
- Decided
- Jun 23, 1999
- Review
- 343 days
- Class
- Class II
- Product code
- DTR
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K923311 (1992). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK923311 Conducer Heat Exchanger3M Health Care, Sarns · 1992
- This deviceK982467 Capiox CardioplegiaTerumo Medical Corp. · 1999
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K923311 | Conducer Heat Exchanger | 3M Health Care, Sarns | 1992 | — |
| 0 (this device) | K982467 | Capiox Cardioplegia | Terumo Medical Corp. | 1999 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1994 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DTR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DTR device
- #1 K252541 Quantum PureFlow Standard Heat Exchanger…score 13.4 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K934847 | Ngbcd & Ngbcdp Cardioplegia Delivery SystemsSummary page 1…tially equivalent to Sorin BCD Vanguard and the Sarns Conducer. The discussion and table below compare the CAPIOX® Cardioplegia with the Sorin BCD Vanguard cleared under K934847 and the Sarns Conducer (K923311). />a7: ofs II - Summary and Certification Summary of Safety and Effectiveness… | 1994 |
| * | K923311 | Conducer Heat ExchangerSummary page 1…anguard and the Sarns Conducer. The discussion and table below compare the CAPIOX® Cardioplegia with the Sorin BCD Vanguard cleared under K934847 and the Sarns Conducer (K923311). />a7: ofs II - Summary and Certification Summary of Safety and Effectiveness Intended Use All the devices are… | 1992 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- 1 of the 2 ancestors has a recall of any class.
- 3 other devices also cite its predicate K934847.
How does its category compare?
All DTR devicesDTR Heat-Exchanger, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DTR
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DTR
Too few DTR 510(k)s in any year since 2007 to give a median.
Recalls per year · DTR
1in 2015
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DTR
44in 2025
MAUDE reports naming product code DTR, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 2 |
| 2008 | 1 | — | 0 | 1 |
| 2009 | 2 | — | 0 | 0 |
| 2010 | 0 | — | 24 | 43 |
| 2011 | 0 | — | 3 | 67 |
| 2012 | 0 | — | 0 | 16 |
| 2013 | 0 | — | 0 | 27 |
| 2014 | 0 | — | 0 | 66 |
| 2015 | 0 | — | 1 | 96 |
| 2016 | 0 | — | 0 | 60 |
| 2017 | 2 | — | 0 | 69 |
| 2018 | 1 | — | 0 | 75 |
| 2019 | 0 | — | 0 | 35 |
| 2020 | 2 | — | 0 | 33 |
| 2021 | 0 | — | 0 | 11 |
| 2022 | 2 | — | 0 | 23 |
| 2023 | 1 | — | 0 | 18 |
| 2024 | 1 | — | 0 | 8 |
| 2025 | 2 | — | 0 | 44 |
| 2026 | 1 | — | 2 | — |
What is it indicated for?
The CAPIOX Cardioplegia is cardiopulmonary bypass heat exchanger consisting
of a heat exchange system used in extracorporeal circulation to warm or cool the
blood or perfusion fluid flowing through the device for periods up to 6 hours.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K982467 · printed Nov 4, 2026
Cite this page
510(k) Report. “K982467: Capiox Cardioplegia.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K982467
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026